Plasma heparin levels and operative/postoperative bleeding were assessed in 16 patients of varying body weights who received subcutaneous low-dose heparin prophylaxis for deep vein thrombosis during and after transurethral resection for benign prostatic hypertrophy. The concentration of heparin in the blood at operation and subsequently was found to vary widely but did not correlate with the extent of blood loss. When adjusted for body weight, plasma heparin concentration showed significantly less variation from patient to patient. In this respect, body weight was a more effective parameter than lean body mass or surface area. Adjustment of heparin dosage by body weight may be advisable when using low-dose heparin prophylaxis.
Introduction
Deep vein thrombosis (DVT) and pulmonary embolism (PE) represent an uncommon but potentially fatal complication of prostatic surgery (Hedlund 1975) . Low-dose subcutaneous heparin (LDH) prophylaxis has been shown to reduce the incidence of DVT and PE in general surgical patients (Kakkar et al. 1975) , but many surgeons have reservations about using this regimen for fear of increasing the risk of operative and postoperative haemorrhage (McWilliam et al. 1974) . In some patients DVT and PE occur despite LDH prophylaxis used in accordance with standard regimens.
The object of the present study was to determine the relationship between plasma heparin concentration and bleeding in patients undergoing transurethral resection (TUR) and to determine whether a flexible rather than a standard protocol should be used for LDH administration.
Methods
Sixteen male patients of varying body build undergoing TUR for benign prostatic hypertrophy received LDH prophylaxis according to the regimen of Kakkar et al. (1975) . Operative and postoperative blood loss was estimated by colorimetric analysis of the irrigating fluid, continuous irrigation of the bladder being used during and after the operation. Plasma heparin concentrations were assayed in triplicate, at the onset of surgery and 2, 4 and 6 hours after the initial sample was taken, using the sensitive method of Teien et al. (1977) . The mean result in each set of three samples was the one recorded. The body weight, height and biceps/triceps skinfold thickness of each patient was measured directly, and the surface area and lean body mass were estimated from these measurements with the aid of nomograms (Reynolds 1982).
Results
Heparin levels and bleeding: Total operative blood loss, blood loss per gram of tissue resected and blood loss per minute of operating time showed no correlation with the concentration of heparin in the blood at the time of operation (Figure 1 ). Postoperatively, heparin levels similarly showed no correlation with subsequent bleeding (Figure 2 Variability of heparin levels: Plasma heparin concentrations showed wide variation from patient to patient, particularly at the time of operation (Figure 3 ). In 6 patients no heparin was detectable in the blood at the time of operation, whilst in 2 patients the levels exceeded 0.2 u/ml and were sufficient to exert a direct anticoagulant effect, the activated partial thromboplastin time in these patients being in excess of 10 seconds over the control time.
Effect ofbody weight, surface area and lean body mass: In order to elucidate whether variation in the available distribution space plays any part in the variability of heparin levels between patients, heparin concentrations were indexed for body weight, lean body mass and surface area. The coefficient of variance was calculated for each of these duly adjusted variables and compared with variance of the unadjusted heparin levels. Variance was reduced by taking account of any of the parameters relating to body size, but body weight accounted better than surface area or lean body mass for the variation in heparin concentration between individuals (Table 1) . Adjusted for lean body mass 30 73
Discussion
Two theoretical risks attach to the use of a-set regimen for LDH prophylaxis in all patients, irrespective of their size. The rate of absorption and metabolism together with the distribution space available and the effects of 'heparin tolerance' must vary from patient to patient, as with any other drug. In some patients prophylaxis fails, which may be because insufficient heparin is present in the circulation at the time of thrombus initiation (Nicolaides et al. 1984) , whilst in others heparin levels may be so high as to exert an anticoagulant effect.
The present results confirm that heparin levels vary widely from patient to patient following subcutaneous injection of a fixed dose. In the context of TUR for benign prostatic disease, this does not appear to be associated with any haemorrhagic sequelae. However, an increased risk of wound haematoma formation in patients undergoing a general surgical operation who have received the standard regimen has previously been established (Kakkar et al. 1975) . The risk appears to be present when heparin levels exceed 0.2 u/ml (Nicolaides et al. 1984) , which occurred in 4 of our patients.
In order to reduce the variability of heparin levels in patients of different body builds, the present results indicate that the dosage of heparin might, with advantage, be adjusted according to body weight. Further work is required to establish whether an adjustable regimen would, in practice, reduce the problems of failure of prophylaxis and excessive bleeding.
